American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1142-1149, (2003)
© 2003 American Thoracic Society
Clinical Research in Chronic Obstructive Pulmonary Disease
Needs and Opportunities
Thomas L. Croxton,
Gail G. Weinmann,
Robert M. Senior,
Robert A. Wise,
James D. Crapo and
A. Sonia Buist
Division of Lung Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland; Departments of Medicine and of Cell Biology and Physiology, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri; Department of Medicine, The Johns Hopkins University, Baltimore, Maryland; Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado; and Department of Medicine, Oregon Health and Science University, Portland, Oregon
Correspondence and requests for reprints should be addressed to Tom Croxton, DLD/NHLBI, Room 10208, 6701 Rockledge Drive, Bethesda, MD 20892-7952. E-mail: croxtont{at}nhlbi.nih.gov
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a common condition, and one difficult to manage. Available treatments, other than smoking cessation, are only minimally effective, and the knowledge basis for clinical decision making is limited. To identify areas in which further clinical research may lead to significant improvements in the care of patients with COPD, the National Heart, Lung, and Blood Institute convened a Working Group, entitled "Clinical Research in COPD: Needs and Opportunities," on March 2122, 2002. This group of experts identified important questions in the field and made the following recommendations: (1) establish a multicenter Clinical Research Network to perform multiple, short-term clinical trials of treatments in patients with moderate-to-severe COPD; (2) create a system for the standardized collection, processing, and distribution of lung tissue specimens and associated clinical and laboratory data; (3) develop standards for the classification and staging of COPD; (4) characterize the development and progression of COPD using measures and biomarkers that relate to current concepts of pathogenesis; and (5) evaluate indications for long-term oxygen therapy for patients with COPD.
Key Words: chronic obstructive pulmonary disease lung diseases, obstructive National Institutes of Health
This article has been cited by other articles:

|
 |

|
 |
 
H. Fehrenbach, R. Voswinckel, V. Michl, T. Mehling, A. Fehrenbach, W. Seeger, and J. R. Nyengaard
Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice
Eur. Respir. J.,
March 1, 2008;
31(3):
515 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Emami, R. V. Cadman, J. M. Woodburn, M. C. Fischer, S. J. Kadlecek, J. Zhu, S. Pickup, R. A. Guyer, M. Law, V. Vahdat, et al.
Early changes of lung function and structure in an elastase model of emphysema--a hyperpolarized 3He MRI study
J Appl Physiol,
March 1, 2008;
104(3):
773 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J.,
November 1, 2007;
30(5):
993 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev,
July 1, 2007;
87(3):
1047 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Niewoehner, Y. Lokhnygina, K. Rice, W. G. Kuschner, A. Sharafkhaneh, G. A. Sarosi, P. Krumpe, K. Pieper, and S. Kesten
Risk Indexes for Exacerbations and Hospitalizations Due to COPD
Chest,
January 1, 2007;
131(1):
20 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhao, J. K. Leung, H. Yamamoto, S. Goswami, F. Kheradmand, and T. H. Vu
Identification of P311 as a Potential Gene Regulating Alveolar Generation
Am. J. Respir. Cell Mol. Biol.,
July 1, 2006;
35(1):
48 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Berry, N. E. Adair, and W. J. Rejeski
Use of Peak Oxygen Consumption in Predicting Physical Function and Quality of Life in COPD Patients
Chest,
June 1, 2006;
129(6):
1516 - 1522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andreas, C. Herrmann-Lingen, T. Raupach, L. Luthje, J. A. Fabricius, N. Hruska, W. Korber, B. Buchner, C-P. Criee, G. Hasenfuss, et al.
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial
Eur. Respir. J.,
May 1, 2006;
27(5):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Hoyt, J. Ballering, H. Numanami, J. M. Hayden, and R. A. Robbins
Doxycycline Modulates Nitric Oxide Production in Murine Lung Epithelial Cells
J. Immunol.,
January 1, 2006;
176(1):
567 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Wright
Make No Bones About It: Increasing Epidemiologic Evidence Links Vitamin D to Pulmonary Function and COPD
Chest,
December 1, 2005;
128(6):
3781 - 3783.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Baraldo, E Bazzan, G Turato, F Calabrese, B Beghe, A Papi, P Maestrelli, L M Fabbri, R Zuin, and M Saetta
Decreased expression of TGF-{beta} type II receptor in bronchial glands of smokers with COPD
Thorax,
December 1, 2005;
60(12):
998 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
November 1, 2005;
2(4):
361 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Andreas, S. D. Anker, P. D. Scanlon, and V. K. Somers
Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease
Chest,
November 1, 2005;
128(5):
3618 - 3624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Niewoehner, K. Rice, C. Cote, D. Paulson, J. A. D. Cooper Jr., L. Korducki, C. Cassino, and S. Kesten
Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial
Ann Intern Med,
September 6, 2005;
143(5):
317 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Murakami, N. Nagaya, T. Itoh, T. Iwase, T. Fujisato, K. Nishioka, K. Hamada, K. Kangawa, and H. Kimura
Adrenomedullin Regenerates Alveoli and Vasculature in Elastase-induced Pulmonary Emphysema in Mice
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
581 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
19 - 38.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Naeije
Pulmonary Hypertension and Right Heart Failure in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2005;
2(1):
20 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Hunninghake
Cardiovascular Disease in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2005;
2(1):
44 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Buhl and S. G. Farmer
Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
April 1, 2005;
2(1):
83 - 93.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakano, J. C. Wong, P. A. de Jong, L. Buzatu, T. Nagao, H. O. Coxson, W. M. Elliott, J. C. Hogg, and P. D. Pare
The Prediction of Small Airway Dimensions Using Computed Tomography
Am. J. Respir. Crit. Care Med.,
January 15, 2005;
171(2):
142 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Parr, B. C. Stoel, J. Stolk, P. G. Nightingale, and R. A. Stockley
Influence of Calibration on Densitometric Studies of Emphysema Progression Using Computed Tomography
Am. J. Respir. Crit. Care Med.,
October 15, 2004;
170(8):
883 - 890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Mercer, N. Kolesnikova, J. Sonett, and J. D'Armiento
Extracellular Regulated Kinase/Mitogen Activated Protein Kinase Is Up-regulated in Pulmonary Emphysema and Mediates Matrix Metalloproteinase-1 Induction by Cigarette Smoke
J. Biol. Chem.,
April 23, 2004;
279(17):
17690 - 17696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.J. Sterk
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1
Eur. Respir. J.,
April 1, 2004;
23(4):
497 - 498.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2003
Am. J. Respir. Crit. Care Med.,
January 15, 2004;
169(2):
301 - 313.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T K Marras, W MacNee, and P M A Calverley
Management of COPD
Thorax,
November 1, 2003;
58(11):
1006 - 1006.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Suki, K. R. Lutchen, and E. P. Ingenito
On the Progressive Nature of Emphysema: Roles of Proteases, Inflammation, and Mechanical Forces
Am. J. Respir. Crit. Care Med.,
September 1, 2003;
168(5):
516 - 521.
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society
|
|
|